2',3'-dideoxyinosine-induced mallory bodies in patients with HIV

American Journal of Clinical Pathology

Volumn 108, Issue 3, 1997, Pages 280-283

  Hu, Bing ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Didanosine (ddI); Empty cells; Human immunodeficiency virus; Mallory bodies; Steatohepatitis

Indexed keywords

DIDANOSINE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; FATTY LIVER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; MALE; MALLORY BODY; PRIORITY JOURNAL;

EID: 0030865874     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.3.280     Document Type: Article

References (15)

1. Lambert JS, Seidlin M, Reichman RC, et al. ddI in patients with the acquired immunodeficiency syndrome or AIDS-related complex: a phase I trial. N Engl J Med. 1990;322:1333-1340.
2. Kahn JO, Lagakos SW, Richman DD, et al. A controlled trial comparing continued zidovudine with didanosine in HIV infection. N Engl J Med. 1992;327:1598-1599.
3. Yarchoan R, Pluda JM, Thomas RV, et al. In vivo activity against HIV and favorable toxicity profile of ddI. Science. 1989;245:412-415.
4. Sieldlin M, Lambert JS, Dolin R, Valentine FT. Pancreatitis and pancreatic dysfunction in patients taking ddI. AIDS. 1992;6:831-835.
5. Bissuel F, Bruneel F, Harcsetzer F, et al. Fulminant hepatitis with severe lactose acidosis in HIV-infected patients on didanosine therapy. J Intern Med. 1994;235:367-372.
6. Lacaille F, Bruneel F, Haresetzer F, et al. Hepatic toxicity associated with dideoxyinosine in children with AIDS. J Pediatr Gastroenterol Nutr. 1995;20:287-290.
7. Lai KK, Gang DL, Zawacki JK, et al. Fulminant hepatic failure associated with 2′,3′-dideoxyinosine. Ann Intern Med. 1991;115:283-284.
8. French SW. Pathology of alcoholic liver disease. Semin Liver Dis. 1993;13:154-169.
9. French SW. Cytokeratin: intermediate filaments. In Arias IM, Boyer U, Fausto N, Jakoby WB, Schachter DA, Shafritz A. The Liver and Pathology. 3rd ed. New York, NY: Raven Press; 1994:33-43.
10. Jensen K, Gluud C. The Mallory body: morphological, clinical and experimental studies (part 1 of a literature survey). Hepatology. 1994;20:1061-1082.
11. French SW, Eislie LB, Freeman J. Nonalcoholic fatty hepatitis: an important clinical condition. Can J Gastroenterol. 1989;3:189-198.
12. Freeman P, Hellcat KE, Hammers MR, et al. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS. 1993;7:379-385.
13. Cooley TP, Kunches LM, Saunders CA, et al. Treatment of AIDS and AIDS-related complex with ddI given once daily. Rev Infect Dis. 1990;12(suppl 5): 552S-560S.
14. Badr MZ. Effects of the anti-AIDS drug dideoxyinosine on hepatic glycolysis in the perfused rat liver: role of intracellular calcium stores. Biochem Pharmacol. 1991;41:146-148.
15. Ohta M, Marceau N, Perry G, et al. Ubiquitin is present on cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest. 1988;59:848-856.